Bill James, a partner in Goodwin Procter's IP Litigation Group, has more than 18 years experience in patent litigation related to pharmaceutical and biotechnology products. He has significant experience with Hatch-Waxman litigations, representing both plaintiffs and defendants, including first-to-file cases and multi-defendant ANDA drug challenges, and has participated in several appeals before the U.S. Court of Appeals for the Federal Circuit.

Dr. James also advises pharmaceutical and biotechnology companies on freedom-to-operate, due diligence, licensing and prosecution issues, and has experience coordinating worldwide patent litigation strategies and providing strategic counseling on biosimilar products.